Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ademola O. Odeniyi"'
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 20:343-365
Parkinson’s Disease (PD) is characterised by degeneration of the neurons of the nigrostriatal dopaminergic pathway of the brain. The pharmacological cornerstone of PD management is mainly the use of dopamine precursors, dopamine receptor agonists,
Autor:
Deborah Amadiegwu, Ademola O. Odeniyi, Oluwadamilare J. Ayeni, Folusho O. Ojo, Adejoke Y. Onaolapo, Hameed A. Yahaya, Stephen O. Jonathan, Olakunle J. Onaolapo, Moyinoluwa O. Samuel, Aisha O. Tiamiyu, Ajoke Olawale
Publikováno v:
Current Aging Science. 14:62-75
Background: Despite decades of research, neurodegenerative disorders like Parkinson’s disease remain a leading cause of disability worldwide, due to the insufficient reduction of disease burden by available medications. Recently, the benefits of di
Autor:
Olakunle J, Onaolapo, Ademola O, Odeniyi, Stephen O, Jonathan, Moyinoluwa O, Samuel, Deborah, Amadiegwu, Ajoke, Olawale, Aisha O, Tiamiyu, Folusho O, Ojo, Hameed A, Yahaya, Oluwadamilare J, Ayeni, Adejoke Y, Onaolapo
Publikováno v:
Current aging science. 14(1)
Despite decades of research, neurodegenerative disorders like Parkinson's disease remain a leading cause of disability worldwide, due to the insufficient reduction of disease burden by available medications. Recently, the benefits of dietary suppleme